VIATRIS INC (VIA.DE) Stock Fundamental Analysis

Europe • Frankfurt Stock Exchange • FRA:VIA • US92556V1061

13.305 EUR
+0.71 (+5.68%)
Last: Feb 10, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

3

Overall VIA gets a fundamental rating of 3 out of 10. We evaluated VIA against 55 industry peers in the Pharmaceuticals industry. VIA may be in some trouble as it scores bad on both profitability and health. VIA is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • VIA had positive earnings in the past year.
  • In the past year VIA had a positive cash flow from operations.
  • In multiple years VIA reported negative net income over the last 5 years.
  • In the past 5 years VIA always reported a positive cash flow from operatings.
VIA.DE Yearly Net Income VS EBIT VS OCF VS FCFVIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B 3B

1.2 Ratios

  • The Return On Assets of VIA (-9.73%) is worse than 76.36% of its industry peers.
  • VIA has a worse Return On Equity (-24.26%) than 80.00% of its industry peers.
  • VIA's Return On Invested Capital of 3.04% is on the low side compared to the rest of the industry. VIA is outperformed by 63.64% of its industry peers.
  • VIA had an Average Return On Invested Capital over the past 3 years of 3.61%. This is significantly below the industry average of 14.21%.
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROIC 3.04%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)3.61%
ROIC(5y)3.17%
VIA.DE Yearly ROA, ROE, ROICVIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5

1.3 Margins

  • The Operating Margin of VIA (9.34%) is worse than 61.82% of its industry peers.
  • VIA's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 39.36%, VIA is doing worse than 78.18% of the companies in the same industry.
  • VIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.34%
PM (TTM) N/A
GM 39.36%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
VIA.DE Yearly Profit, Operating, Gross MarginsVIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • VIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for VIA has been reduced compared to 1 year ago.
  • The number of shares outstanding for VIA has been increased compared to 5 years ago.
  • The debt/assets ratio for VIA has been reduced compared to a year ago.
VIA.DE Yearly Shares OutstandingVIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
VIA.DE Yearly Total Debt VS Total AssetsVIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • VIA has an Altman-Z score of 1.05. This is a bad value and indicates that VIA is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.05, VIA is doing worse than 72.73% of the companies in the same industry.
  • VIA has a debt to FCF ratio of 8.96. This is a slightly negative value and a sign of low solvency as VIA would need 8.96 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 8.96, VIA is doing worse than 60.00% of the companies in the same industry.
  • VIA has a Debt/Equity ratio of 0.82. This is a neutral value indicating VIA is somewhat dependend on debt financing.
  • VIA has a Debt to Equity ratio of 0.82. This is comparable to the rest of the industry: VIA outperforms 41.82% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Altman-Z 1.05
ROIC/WACC0.39
WACC7.73%
VIA.DE Yearly LT Debt VS Equity VS FCFVIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.3 Liquidity

  • VIA has a Current Ratio of 1.35. This is a normal value and indicates that VIA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of VIA (1.35) is comparable to the rest of the industry.
  • VIA has a Quick Ratio of 1.35. This is a bad value and indicates that VIA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • VIA has a Quick ratio of 0.79. This is in the lower half of the industry: VIA underperforms 67.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 0.79
VIA.DE Yearly Current Assets VS Current LiabilitesVIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • VIA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -14.65%.
  • VIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.73% yearly.
  • Looking at the last year, VIA shows a decrease in Revenue. The Revenue has decreased by -6.14% in the last year.
  • The Revenue has been growing slightly by 5.09% on average over the past years.
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%

3.2 Future

  • VIA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.45% yearly.
  • Based on estimates for the next years, VIA will show a small growth in Revenue. The Revenue will grow by 0.49% on average per year.
EPS Next Y-10.82%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
EPS Next 5Y4.45%
Revenue Next Year-4.74%
Revenue Next 2Y-1.77%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VIA.DE Yearly Revenue VS EstimatesVIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
VIA.DE Yearly EPS VS EstimatesVIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

7

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.79, the valuation of VIA can be described as very cheap.
  • VIA's Price/Earnings ratio is rather cheap when compared to the industry. VIA is cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 28.23. VIA is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 6.26, which indicates a rather cheap valuation of VIA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of VIA indicates a rather cheap valuation: VIA is cheaper than 100.00% of the companies listed in the same industry.
  • When comparing the Price/Forward Earnings ratio of VIA to the average of the S&P500 Index (28.01), we can say VIA is valued rather cheaply.
Industry RankSector Rank
PE 6.79
Fwd PE 6.26
VIA.DE Price Earnings VS Forward Price EarningsVIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VIA indicates a rather cheap valuation: VIA is cheaper than 81.82% of the companies listed in the same industry.
  • 90.91% of the companies in the same industry are more expensive than VIA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.31
EV/EBITDA 7.68
VIA.DE Per share dataVIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.3%
EPS Next 3Y1.4%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.67%, VIA has a reasonable but not impressive dividend return.
  • VIA's Dividend Yield is a higher than the industry average which is at 1.94.
  • Compared to an average S&P500 Dividend Yield of 1.79, VIA pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.67%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years3
VIA.DE Yearly Dividends per shareVIA.DE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • VIA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-15.34%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
VIA.DE Yearly Income VS Free CF VS DividendVIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

VIATRIS INC

FRA:VIA (2/10/2026, 7:00:00 PM)

13.305

+0.71 (+5.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-06
Earnings (Next)02-26
Inst Owners86.94%
Inst Owner ChangeN/A
Ins Owners0.25%
Ins Owner ChangeN/A
Market Cap15.32B
Revenue(TTM)14.12B
Net Income(TTM)-3.69B
Analysts72.22
Price Target11.14 (-16.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.67%
Yearly Dividend0.41
Dividend Growth(5Y)N/A
DP-15.34%
Div Incr Years0
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.6%
Min EPS beat(2)5.83%
Max EPS beat(2)9.36%
EPS beat(4)3
Avg EPS beat(4)2.01%
Min EPS beat(4)-7.28%
Max EPS beat(4)9.36%
EPS beat(8)4
Avg EPS beat(8)1.01%
EPS beat(12)7
Avg EPS beat(12)1.49%
EPS beat(16)10
Avg EPS beat(16)1.8%
Revenue beat(2)2
Avg Revenue beat(2)1.72%
Min Revenue beat(2)1.3%
Max Revenue beat(2)2.14%
Revenue beat(4)2
Avg Revenue beat(4)-0.56%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)2.14%
Revenue beat(8)2
Avg Revenue beat(8)-1.25%
Revenue beat(12)2
Avg Revenue beat(12)-1.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.17%
PT rev (1m)2.7%
PT rev (3m)7.38%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-1.36%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)1.35%
Revenue NQ rev (1m)-0.14%
Revenue NQ rev (3m)0.84%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)1.42%
Valuation
Industry RankSector Rank
PE 6.79
Fwd PE 6.26
P/S 1.29
P/FCF 11.31
P/OCF 9.19
P/B 1.2
P/tB N/A
EV/EBITDA 7.68
EPS(TTM)1.96
EY14.73%
EPS(NY)2.13
Fwd EY15.98%
FCF(TTM)1.18
FCFY8.84%
OCF(TTM)1.45
OCFY10.88%
SpS10.31
BVpS11.11
TBVpS-5.28
PEG (NY)N/A
PEG (5Y)N/A
Graham Number22.13
Profitability
Industry RankSector Rank
ROA -9.73%
ROE -24.26%
ROCE 4.32%
ROIC 3.04%
ROICexc 3.15%
ROICexgc 13.22%
OM 9.34%
PM (TTM) N/A
GM 39.36%
FCFM 11.41%
ROA(3y)0.91%
ROA(5y)-0.13%
ROE(3y)2.24%
ROE(5y)-0.48%
ROIC(3y)3.61%
ROIC(5y)3.17%
ROICexc(3y)3.71%
ROICexc(5y)3.25%
ROICexgc(3y)15.92%
ROICexgc(5y)15.63%
ROCE(3y)5.12%
ROCE(5y)4.54%
ROICexgc growth 3Y-9.04%
ROICexgc growth 5Y-13.17%
ROICexc growth 3Y4.9%
ROICexc growth 5Y-4.57%
OM growth 3Y2.29%
OM growth 5Y-3.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.33%
GM growth 5Y1.02%
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity 0.82
Debt/FCF 8.96
Debt/EBITDA 3.05
Cap/Depr 13.37%
Cap/Sales 2.63%
Interest Coverage 250
Cash Conversion 48.4%
Profit Quality N/A
Current Ratio 1.35
Quick Ratio 0.79
Altman-Z 1.05
F-Score4
WACC7.73%
ROIC/WACC0.39
Cap/Depr(3y)14.64%
Cap/Depr(5y)17.2%
Cap/Sales(3y)2.72%
Cap/Sales(5y)3.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.65%
EPS 3Y-10.45%
EPS 5Y-9.73%
EPS Q2Q%-10.67%
EPS Next Y-10.82%
EPS Next 2Y-2.3%
EPS Next 3Y1.4%
EPS Next 5Y4.45%
Revenue 1Y (TTM)-6.14%
Revenue growth 3Y-6.25%
Revenue growth 5Y5.09%
Sales Q2Q%0.23%
Revenue Next Year-4.74%
Revenue Next 2Y-1.77%
Revenue Next 3Y-0.58%
Revenue Next 5Y0.49%
EBIT growth 1Y-2.47%
EBIT growth 3Y-4.1%
EBIT growth 5Y1.89%
EBIT Next Year-4.89%
EBIT Next 3Y0.92%
EBIT Next 5Y1.31%
FCF growth 1Y-20.35%
FCF growth 3Y-7.94%
FCF growth 5Y6.95%
OCF growth 1Y-19.49%
OCF growth 3Y-8.61%
OCF growth 5Y5.01%

VIATRIS INC / VIA.DE FAQ

What is the fundamental rating for VIA stock?

ChartMill assigns a fundamental rating of 3 / 10 to VIA.DE.


What is the valuation status of VIATRIS INC (VIA.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to VIATRIS INC (VIA.DE). This can be considered as Undervalued.


How profitable is VIATRIS INC (VIA.DE) stock?

VIATRIS INC (VIA.DE) has a profitability rating of 2 / 10.


Can you provide the expected EPS growth for VIA stock?

The Earnings per Share (EPS) of VIATRIS INC (VIA.DE) is expected to decline by -10.82% in the next year.


Can you provide the dividend sustainability for VIA stock?

The dividend rating of VIATRIS INC (VIA.DE) is 3 / 10 and the dividend payout ratio is -15.34%.